ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state.
Wookbong KwonSeong-Kyoon ChoiDaehwan KimHyeon-Gyeom KimJin-Kyu ParkJee Eun HanGil-Jae ChoSungho YunWookyung YuSe-Hyeon HanYun-Sok HaJun Nyung LeeTae Gyun KwonDong-Hyung ChoJun-Koo YiMyoung Ok KimZae Young RyooSong ParkPublished in: Journal of experimental & clinical cancer research : CR (2021)
Our findings suggest that ZNF507 is a novel key regulator of TGF-β signaling in the progression of malignant PC and could be a promising target for studying the development of advanced metastatic PCs.